A Phase IV Prospective Open Label Interventional Multi center Single arm Post market surveillance study to confirm the safety and efficacy of Intra articular Injection of CINGAL Cross Linked Sodium Hyaluronate 88mg with Triamcinolone Hexacetonide 18mg in the Management of Knee Osteoarthritis Kellgren lawrence grades I III in the Indian population
A prospective, single-arm, multi-centre clinical study to determine the efficacy, safety and tolerability ofWinderma Scar Gel in improving the overall appearance of old and new scars - NIL
A prospective, randomized, open-label, active-controlled, parallel-group clinical study to evaluate the efficacy and safety of HepaMerz OA syrup containing L-Ornithine L-Aspartate 250 mg per 5ml as supportive and maintenance therapy along with standard of care versus standard of care alone in patients with acute hepatitis of varied etiology. - Nil
100 项与 Modi-Mundi Pharma Pvt Ltd. 相关的临床结果
0 项与 Modi-Mundi Pharma Pvt Ltd. 相关的专利（医药）
100 项与 Modi-Mundi Pharma Pvt Ltd. 相关的药物交易
100 项与 Modi-Mundi Pharma Pvt Ltd. 相关的转化医学
